Skip to main content
. Author manuscript; available in PMC: 2020 Mar 4.
Published in final edited form as: Otolaryngol Head Neck Surg. 2020 Jan 7;162(3):304–312. doi: 10.1177/0194599819898861

Table 1.

Sociodemographic, Oncologic, and Psychosocial Characteristics of the Study Cohort (N = 68).

Characteristic Median (IQR) or n (%)
Age, y 63 (53–72.25)
Sex
 Female 25 (37)
 Male 43 (63)
Race
 White 55 (81)
 African American 11 (16)
 Other 2 (3)
Marital status
 Married/current partner 38 (56)
 Single/separated/divorced/widowed 30 (44)
Body mass index
 Underweight 3 (4)
 Normal weight 26 (38)
 Overweight/Obese 39 (57)
Preoperative mood disorder diagnosis
 No 45 (66)
 Yes 23 (34)
Preoperative psychiatric medication
 No 45 (66)
 Yes 23 (34)
Preoperative hypothyroidism
 No 53 (78)
 Yes l5 (22)
Shame and stigma scale scorea 16 (10–25)
PROMIS SF 4a score
 Anxietyb 10 (7–13)
 Depressionb 6 (4–10)
 Social isolation 4 (4–9)
Tumor location and histology
 Oral cavity SCC 37 (54)
 Oropharynx SCC/SCC of unknown primary 8(12)
 Larynx/hypopharynx SCC 9(13)
 Facial cutaneous malignancy 14(21)
pl6 status (oropharynx cases only)
 Negative 3 (38)
 Positive 5 (63)
AJCC pathologic T classification
 0-2 32 (47)
 3-4b 36 (53)
Ablative surgeryc
 Mandibulectomy 13(19)
 Glossectomy 37 (54)
 Maxillectomy 5 (7)
 Radical tonsillectomy/pharyngectomy 5 (7)
 Total laryngectomy 6 (9)
 Skin/soft tissue resection and/or parotidectomy 18 (26)
 Neck dissection 60 (88)
 Other 6 (9)
Reconstructive surgery
 None or dermal substitute 17 (25)
 Regional flap 6 (9)
 Microvascular free flap 45 (66)
Osseous microvascular free flap reconstruction
 No 56 (83)
 Yes 12 (18)
Adjuvant therapy
 None 26 (41)
 Radiation 23 (36)
 Chemoradiationd 15 (23)

Abbreviations: AJCC, American Joint Committee on Cancer; IQR, Interquartile range; PROMIS SF, Patient-Reported Outcomes Measurement Information System Short Form; SCC, squamous cell carcinoma.

a

n = 65 due to missing data (n = 3).

b

n = 67 due to missing data (n = 1).

c

n > 68 as patients may belong to > 1 category.

d

n = 64 due to mortality prior to adjuvant therapy (n = 3) and lost to follow-up (n = 1).